pharma · COPD
Kwong Wah Hospital
Kwong Wah Hospital is a pharma organization headquartered in CN. Primary therapeutic focus areas include COPD. NovaPharmaNews links 1 clinical program(s), 0 drug profile(s), and 0 patent record(s) to this entity from pub
CN HQ
NMPA registrant Type
Company details
- Status
- Public
- HQ
- CN
- Programs
- 1
- Drugs
- 1
- Patents
- 0
N-acetycysteine (600mg twice daily)
Approved · small molecule · COPD
N-acetycysteine (600mg twice daily) for COPD is a Approved program (small_molecule) at Kwong Wah Hospital with 1 ClinicalTrials.gov record(s).
Internal code KW/EX/09-140
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- Kwong Wah Hospital
- Phase
- Approved
- Modality
- small_molecule
- Indication
- COPD
- Status
- completed
- Trials
- 1